PMID: 12832109
pharmacies in FDA-regulated facilities
Increased Risk of Rare Complications While rare, serious conditions like pancreatitis (inflammation of the pancreas) or gallbladder issues are associated with GLP-1 medications
PETROLATUM, BIS-DIGLYCERYL POLYACYLADIPATE-2, SQUALANE, BUTYROSPERMUM PARKII BUTTER, DIGLYCERYL ADIPATE/CAPRATE/CAPRYLATE/HYDROXYSTEARATE, AVENA SATIVA KERNEL OIL, PRUNUS AMYGDALUS DULCIS OIL, TRITICUM VULGARE GERM OIL, CANDELILLA CERA, JOJOBA ESTERS, BISABOLOL, ALLANTOIN, ALOE BARBADENSIS LEAF EXTRACT, CARTHAMUS TINCTORIUS SEED OIL, CHOLESTEROL, RETINYL PALMITATE, TOCOPHEROL, VANILLA PLANIFOLIA FRUIT EXTRACT, GLYCINE SOJA OIL
These signaling pathways may be related to the other results, such as the reduction of the production of chemokines and pro-inflammatory cytokines, such as IL-6, TGF-, and TNF- in TH cells, as well as the expression of adhesin (CD11b) and chemokines, such as CCL-2 (MCP-1) in monocytes (He et al., 2013